NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...
The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
Recommended Videos According to the board, the neurosurgeon gave a patient an overdose of lidocaine, a numbing medication, which caused the patient to have a seizure and nearly go into cardiac arrest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback